Staphylococcus prevails in the skin microbiota of long-term immunodeficient mice by Garcia-Garcerà, Marc et al.
1 
 
Staphylococcus prevails in the skin microbiota of long-term immunodeficient mice. 1 
Marc Garcia-Garcerà1,4 Mireia Coscollà1,2, Koldo Garcia-Etxebarria1, Juan Martín-2 
Caballero3, Fernando González-Candelas4, Amparo Latorre4, Francesc Calafell1 3 
 4 
1 Institut de Biologia Evolutiva CSIC-UPF, Dr.Aiguader 88, 08003 Barcelona, Spain 5 
2 Swiss Tropical and Public Health Institute, Basel, Switzerland 6 
3 Animal Facility, Parc de Recerca Biomèdica de Barcelona, Dr.Aiguader 88, 08003 7 
Barcelona, Spain 8 
4 Joint Research Unit on Genomics and Health, Centre for Public Health Research 9 
(CSISP) and Cavanilles Institute for Biodiversity and Evolutionary Biology (University of 10 
Valencia). Av. Catalunya, 20 46020. Valencia. Spain. 11 
Corresponding Author 12 
Francesc Calafell 13 
Institute of Evolutionary Biology (UPF-CSIC) 14 
Dr. Aiguader 88 15 
08003 Barcelona (Spain) 16 
Phone: +34933160803 17 
Email: francesc.calafell@upf.edu 18 
 Running title: microbiota shifts in immunodeficient mouse skin 19 
20 
2 
 
SUMMARY 1 
 2 
Host-commensal relationships in the skin are a complex system governed by variables 3 
related to the host, the bacteria, and the environment. A disruption of this system may 4 
lead to new steady states, which, in turn, may lead to disease. We have studied one 5 
such disruption by characterizing the skin microbiota in healthy and immunodepressed 6 
(ID) mice. A detailed anatomopathological study failed to reveal any difference between 7 
the skin of healthy and ID mice. We sequenced the 16S rDNA V1-V2 gene region to 8 
saturation in ten healthy and ten ID 8-week old mice, and found than all of the healthy 9 
and two of the ID mice had bacterial communities that were similar in composition to 10 
that of human skin, although, presumably because of the uniform raising conditions, 11 
less interindividual variation was found in mice. However, eight ID mice showed 12 
microbiota dominated by Staphylococcus epidermidis. Quantitative PCR amplification of 13 
16S rDNA gene and of the Staphylococcus-specific TstaG region confirmed the 14 
previous results and indicated that the quantitative levels of Staphylococcus were 15 
similar in both groups while the total number of 16S copies was greater in the healthy 16 
mice. Thus, it is possible that, under long-term immunodeficiency, which removes the 17 
acquired but not the native immune system, Staphylococcus epidermidis may inhibit the 18 
growth of other bacteria but does not cause a pathogenic state. 19 
 20 
 21 
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INTRODUCTION 1 
 2 
 The skin, as the most external body barrier, protects the organism against 3 
external aggressions and infections. Skin is also the first organ that interacts with the 4 
external environment, allowing non-pathogenic microorganisms to coexist and interact 5 
mutualistically with the organism(Roth & James 1988). The mammalian skin, as many 6 
other ecosystems, consists of a structurally complex surface with multiple niches 7 
according to environmental, physical and chemical characteristics. All of its 8 
appendages, invaginations, and glands turn the skin into the most complex ecosystem 9 
of the human body, which is colonized by a wide range of microorganisms(Grice & 10 
Segre 2011; Rosenthal et al. 2011). 11 
 Although less than 5% of bacterial species are culturable, molecular approaches 12 
allow characterizing the bacterial diversity in a given ecosystem using the 16S 13 
ribosomal RNA unit as a phylogenetic marker(Amann et al. 1995). The ability to amplify 14 
and sequence the whole range of bacterial 16S rRNA using a set of universal primers 15 
plus the revolution of next generation sequencing platforms provide sufficient 16 
information to assess and compare bacterial diversity in different skin niches in terms of 17 
space, time, and state (Hugenholtz & Pace 1996; Turnbaugh et al. 2007). 18 
 Bacterial-host skin interactions range from immune system collaboration to 19 
external layer post-processing(Roth & James 1988). The indigenous microbiota may 20 
play an important role in skin immunity following two different mechanisms: firstly, 21 
resident bacteria may have a main role in the activation of the immune system, enabling 22 
4 
 
the expansion and maintenance of the CD8+ lymphocyte population in skin, preventing 1 
the development of allergic disease, and also stimulating the Toll-like receptors (TLRs) 2 
in keratinocytes and dendritic cells that will respond more effectively and efficiently to 3 
pathogenic insults(Cogen et al. 2008). Secondly, commensal bacteria may actively 4 
inhibit the growth of pathogenic bacteria, by secreting signal molecules that activate the 5 
expression of host antimicrobial peptides (AMPs) and recruit AMPs to the skin. The 6 
indigenous microbiota may also block pathogen quorum sensing, interfering the 7 
progression of the infection (Otto 2009; Mehta et al. 2009). 8 
 As in many other systems, complex interactions may lead to complex behaviors 9 
that can result pathogenic to the host, under certain host genetic predispositions. 10 
Specific microorganism-disease relationships have been suggested for complex 11 
disorders such as psoriasis, or atopic dermatitis(Fredricks 2001). But, although some 12 
evidence for changes in microbial composition under disease has been shown(Gao et 13 
al. 2008), there is no evidence for a  disease being caused by such a change. However, 14 
given the complex interactions and functions of the skin microbiota in the development 15 
of the immune system, the study of the possible trigger effect of the microbiota in 16 
complex diseases such as atopic dermatitis or psoriasis is interesting. Nevertheless, 17 
disease and healthy states should be compared with caution, as any change in 18 
microbial composition may be a consequence, rather than a cause, of the 19 
environmental condition change brought on by disease. 20 
 The alteration of the immune system homoeostasis can be considered as a 21 
change in the state of the whole ecosystem. This environmental change may affect the 22 
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fitness of the different bacterial communities, mostly those that interact more intensely 1 
with the immune system. The change in fitness will depend on the relationship between 2 
the bacterial species and the immune system, and it can lead to a significant reduction, 3 
even complete depletion, of the bacterial diversity if the environment change is 4 
maintained through time. This implies that, over time, the change in species 5 
composition will be more dramatic, thus making it harder to find any posited subtle 6 
triggering factor. 7 
 Here we have studied skin bacterial diversity after long term immunodeficiency 8 
using mice as a model. We have compared ID- to normal healthy- (wild type) skin, and 9 
observed a strong reduction in bacterial diversity that was not related to any skin 10 
pathogenic state(Ley et al. 2006). 11 
12 
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RESULTS 1 
Anatomopathology of ID mouse skin 2 
Healthy (H) and ID mice, as explained in the Methods section, were born and housed 3 
together in the same room, with similar interaction protocols to reduce stress levels. 4 
Hygienic and feeding procedures were identic for both cohorts. The housing protocol 5 
allowed the exchange of microbiota among the cohort, to reduce the possible 6 
environmental variability. A careful observation of the skin did not show any skin lesion 7 
in either H or ID mice susceptible of cutaneous infection or inflammatory disease. A 8 
more detailed anatomopathological observation of the ID-mouse skin did not show 9 
neither acanthosis nor hyperkeratosis, features common to ichtyiotic disorders. Other 10 
epidermal alterations such as spongiosis or keratinocyte ballooning, associated with 11 
acute flares of atopic dermatitis, were also absent. Psoriasiform hyperplasia, 12 
characterized by the expansion of the dermal papillae through keratinocyte 13 
hyperproliferation was neither present in ID mice. Both healthy- and ID-mouse skin 14 
showed a thin flat epidermis, with two or three layers of normal keratinocytes. Stratum 15 
Spinosum was not observed in either healhy- or ID-mouse skin. This absence is 16 
characteristic of hairy regions where hair, rather than epidermis thickness, acts as the 17 
main protector for skin. Since ID mice are albino and healthy C57BL/6J mice are not 18 
and have black hair, melanin was only found on the bottom of the hair follicle of healthy 19 
mice, as expected. Hair follicles in both skin types were normal, and different only in 20 
color. Immunohystochemical analysis showed low, normal levels of CD3+, CD4+/CD8+ 21 
and CD56+ cells in healthy uninfected skin. Given that levels of lymphocytes in skin are 22 
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quite low they were unable to differentiate between healthy and ID skin, which seemed 1 
perfectly normal. At the vascular level, low levels of lymphocyte infiltration were 2 
observed in both skin types, making them undistinguishable at this level too. No 3 
alteration in the number of eosinophilic/basophilic cells was evident in either of both skin 4 
types. In summary, no structural or cytological differences were observed between ID- 5 
and healthy-mouse skin that could relate ID mice with any of the most common 6 
inflammatory/immune skin disorders even under the immunodepressed condition of the 7 
ID mice. 8 
 9 
Diversity in mouse skin microbiota 10 
 The V1-V2 region of the 16S rDNA gene was amplified from skin samples of 8 11 
week-old mice, an age that may be sufficient for the microbiota to colonize normal skin 12 
and reach a stable composition. Amplicons were sequenced using the FLX-Titanium 13 
platform, to a depth that reached the plateau of the rarefaction curve. A total of 158,541 14 
sequences was obtained; after applying all filters, 143,908 sequences were used for 15 
further analyses, with an average 7,200 sequences per sample (range 3,554 - 15,261). 16 
  A total of 13 bacterial phyla was found in healthy mice (Figure 1), with >70% of 17 
sequences assigned to Proteobacteria, followed by Firmicutes (5-15%), Bacteroidetes 18 
(1-10%) and Actinobacteria (0.5-5%). A total of 167 genera was present in healthy 19 
samples, 138 of which were represented by more than three sequences. Only 15 20 
genera were present in all healthy samples; four of these represented ~70% of the 21 
sequences: Acinetobacter (23%), Escherichia/Shigella (20%), Acidovorax (13%), and 22 
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Diaphorobacter (12%), all of them previously described in mammalian skin(Grice et al. 1 
2008; Grice et al. 2009). Other characteristic genera such as Corynebacterium, 2 
Propionibacterium, Comamonas, Bacteroides, and Staphylococcus were also present at 3 
lower frequencies in all healthy samples (see suppl. table 1 for detailed information on 4 
the taxonomic assignment). A slightly higher number of genera was found in other 5 
human skin studies by sequencing 16S rDNA at a comparable depth. However, 6 
interindividual differences were greater in humans(Grice et al. 2008). In contrast, ID 7 
mice skin diversity was severely reduced, with more than 90% of the sequences 8 
assigned to Staphylococcus spp. in 6 of 10 samples and more than 60% in all but two 9 
samples, which showed a microbiota composition similar to that of healthy samples. 10 
Staphylococcus sequences were in an average frequency of 5.2% in  healthy samples, 11 
with a range of 0.5%-10%. Bacterial diversity was estimated for each sample with 12 
Shannon and Chao1 indices (table 1), and compared between sample type using a two-13 
tailed t-test. ID mice were much less diverse than healthy ones (p-value=0.0074), even 14 
though they were raised under the same environmental conditions, including 15 
temperature, humidity, food and water access, and, as stated above, their skins were 16 
anatomically identical. Sample clustering was tested using correspondence analysis. 17 
Samples from the same type clustered together in a 2D plot, with the only exception of 18 
the two samples with a healthy-like distribution, as expected (Figure 2). 19 
 20 
Validation of Staphylococus levels  21 
 Preferential amplification of the Staphylococcus sequences with the 16S rDNA 22 
9 
 
primers could partially explain these results. As a control, quantitative PCR (qPCR) was 1 
performed with both the 16S rRNA gene, and the Staphylococcus-specific TstaG region. 2 
After normalization, Cq50, defined as the time point where half of the maximum intensity 3 
is achieved, was calculated by inference and compared between TstaG and 16S rDNA 4 
amplifications on each sample group (Suppl. Figure 2). Interestingly, both curves from 5 
ID mouse samples nearly overlapped in all but two samples (t-test p-value=0.0594) 6 
indicating that, according to diversity results, most bacteria in the ID skin were indeed 7 
Staphylococcus spp. Moreover, the two outliers that behaved like healthy samples in 8 
their 16S rDNA sequences (see above) were also the two samples that amplified 9 
independently in qPCR amplifications. In contrast, healthy skin qPCR curves were 10 
different for both regions (16S and TstaG), and fitted correctly with the diversity results 11 
(t-test p-value= 0.00125). Cq50 differences were obtained by substraction and the 12 
normal distribution was tested the using Lillefors test (p-value>0.05). Cq50 differences 13 
in both ID and healthy mouse skin samples were then compared using an unpaired two-14 
tailed t-test. Significant differences were observed between ID and healthy samples (p-15 
value= 0.0074); that is, the amount of 16S copies present in healthy mouse skin was 16 
significantly larger than in ID mice. Hence, the diversity shift observed in the sequencing 17 
experiments cannot be attributed to primer bias in the Staphylococcus species. 18 
 19 
Staphylococcus diversity in H and ID mice  20 
 We compared the distribution of Staphylococcaceae phylotypes between healthy- 21 
and ID mice. From the 143,908 sequences used for the study, 64,641 sequences were 22 
10 
 
assigned to Staphylococcus by the RDP database(Maidak et al. 2001; Cole et al. 2007). 1 
All these sequences, regardless sample origin, were clustered at 98% identity into 641 2 
phylotypes. Together with the RDP reference sequences, a phylogenetic tree was 3 
constructed to assess the relationship between the references and the reads. As 4 
expected, all phylotypes were located on the genus Staphylococcus node, and were 5 
widely distributed among lower levels of the taxa, with no outlier in the remaining genera 6 
of the family (Figure 3). One of the main issues was the presence of phylotypes 7 
assigned to Staphylococcus aureus, which is a biomarker of opportunistic pathogenicity. 8 
This species was rare in our samples: only singletons assigned to S. aureus were 9 
found, representing less than 0.5% of all sequences assigned to the Staphylococcus 10 
genus. Phylotypes assigned to S. epidermidis were much more frequent. Diversity 11 
analyses of the phylotypes assigned to Staphylococcus did not show significant 12 
differences between sample types (t-test p-value=0.21) or within samples of the same 13 
type (ANOVA p-value(H)=0.09, p-value(ID)=0.42) when relative Shannon indexes were 14 
compared. However, in most samples, regardless their origin, more than 50% of 15 
Staphylococcus assigned sequences were classified  into one main phylotype. In all but 16 
two of the ID samples, S. epidermidis was the most prevalent taxon.17 
11 
 
 1 
 DISCUSSION 2 
 The work we present focuses on microbial diversity of mammal skin under a 3 
highly controlled environment using mice as a model. Given that skin is the most 4 
external layer in mammalian bodies, we expect that its microbial composition is highly 5 
influenced by the environment, and in consequence, high levels of interindividual 6 
variability, depending on the different environments the individual has been in contact 7 
with. Previous studies on the microbial diversity of skin, most of them focused in human 8 
skin, have reported a high inter- and intra- individual variability (Fierer et al. 2010; 9 
Costello et al. 2009). These different results could be due to differences in the sampling 10 
method used. While previous studies controlled only a few minimum elements of the 11 
complex system (hygiene, antibiotic intake, etc), we have performed a curated method 12 
of selection of the sampling region of individuals that were grown in a highly controlled 13 
environment, with controlled patterns of interaction and isolation. The high 14 
environmental homogeneity of the samples results in a high reproducibility of the 15 
variability observed in the same cohort, thus leading to a high statistical confidence. 16 
Moreover, the reduction in noise has allowed us to reveal equivalences among samples 17 
of both cohorts. Despite the fact that more than 90% of sequences in ID mice were 18 
assigned to Staphylococcus sp., it is interesting to note that the remaining sequences in 19 
ID samples were assigned to the most prevalent genera of healthy samples, suggesting 20 
that the initial colonization was similar for all mice, given their common growth 21 
environment. Correspondence Analysis (PCoA) Component 1 (DCA1), which explains 22 
12 
 
72% of the diversity, links perfectly with the relative abundance of Staphylococcus spp. 1 
assigned reads. But more interestingly, the association of high values of DCA1 with 2 
Actinobacteria reads suggests that this phylum is highly associated to the skin, and 3 
tends to be more resistant to displacement by Staphylococcus spp. But the evolution of 4 
ID samples resulted in the complete displacement of Staphylococcus species, by the 5 
competition and inhibition of the other taxa. On the other hand, healthy mice evolved 6 
maintaining the diversity or even acquiring new phylotypes that would fit in the niche.  7 
 Despite the actual differences in variability, we have found that healthy-mouse 8 
skin has a similar bacterial composition to that found in human skin, according to 9 
previous reports. Given the drastic variation in composition depending on the sampled 10 
region, our results agree with those reported by Grice et al., who sampled the forearm 11 
region (Grice et al. 2008). Although the high levels of Proteobacteria are uncommon in 12 
other skin regions, the results by Grice et al., both in humans and mice, were similar to 13 
ours. More interestingly, we have found that the skin of all but two of the 8-week old ID 14 
mice we have analyzed showed higher 16S Quantification Cycle (Cq) levels in qPCR 15 
analyses, which implies that less bacteria were present in ID-mice skin than in that of 16 
healthy mice. Although both types of mice harbored similar quantitative levels of 17 
Staphylococcus according to the qPCR experiments, this genus dominated the 18 
microbiota of ID-mouse skin. One of the main concerns was the susceptibility of BALB/c 19 
mice to S. aureus infections(Köckritz-Blickwede et al. 2008). In agreement with the 20 
anotomopathological study showing no visible lesions in the skin of either H or ID mice, 21 
low levels of S.aureus in the commensal skin microbiota suggests different processes 22 
13 
 
involving systemic susceptibility to nosocomial infection of pathogenic strains of S. 1 
aureus and skin microbiota diversity. One possible explanation for the dominance of S. 2 
epidermidis could be that in ID mice (which have anatomically and immunologically 3 
normal skin), Staphylococcus inhibits the growth of most other bacteria, a process that 4 
may still be under way at 8 weeks, since two ID mice showed normal bacterial profiles. 5 
 Staphyloccocus epidermidis, the most abundant species in our samples, is one of 6 
the main commensals of skin, being almost ubiquitous in all skin regions(Galdbart et al. 7 
2000; Costello et al. 2009), but is also one of the main nosocomial pathogens(Uçkay et 8 
al. 2009). This duality of the  relationship of S.epidermidis with the host has recently 9 
become of great interest (Jean-Baptiste et al. 2011). However, despite the opportunistic 10 
pathogenesis, S.epidermidis has a mostly benign relationship with the host, by a 11 
combination of a low virulence potential (compared to other Staphylococcus species) 12 
and the ability to evade both innate and acquired host defenses(Otto 2009). Thus, 13 
S.epidermidis is able to avoid cationic antimicrobial peptides (AMPc), one of the main 14 
systems of the host innate defense.The AMPc-mediated signal transduction activates 15 
the expression of the dlt operon and the mprF gene, which leads to decreased atraction 16 
of additional AMPc(Peschel et al. 1999; Peschel et al. 2001) by lowering the negative 17 
charge of S. epidermidis cell surface. Moreover, S.epidermidis has been proposed to 18 
have a probiotic function in healthy skin by preventing the colonization of other 19 
pathogens such as S.aureus(Otto et al. 2001). However, according to our results under 20 
immunodepression, the antimicrobial activity of S. epidermidis could result in the 21 
depletion of almost all possible competitors. Cross-inhibition of the quorum sensing 22 
14 
 
system is one of the main mechanisms that S. epidermidis uses to compete against 1 
other bacteria. Staphylococcus quorum sensing is activated by the recognition of the so-2 
called bacterial pheromones (auto-induced peptides AIPs) by the agr system, which in 3 
S.epidermidis seems to be able to inhibit other Staphylococcus species (Otto 2001). 4 
Whether this mechanism applies to other bacteria is not known yet. And, even if this is 5 
the case, the mechanism used by Staphylococcus to inhibit the growth of other taxa 6 
remains also unclear. Other mechanisms, such as the production of Epidermicin NI01, 7 
have been proved to inhibit the growth of a wide range of gram-positive bacteria, 8 
including other Staphylococci (Sandiford & Upton 2012). A broader antimicrobial activity 9 
has been observed in other taxa such as in Enterococcus durans. This bacteria 10 
produces a 5KDa bacteriocin that inhibits the growth of a broad range of gram-positive 11 
and gram-negative bacteria (Line et al. 2008). But it is unknown if this is the case in S. 12 
epidermidis, and further research is needed in this field. S. epidermidis is also able to 13 
activate the innate immune system to reduce the possibility of infection. S. epidermidis, 14 
through the activation of TLR2, is able to increase the expression of ß-defensins and 15 
inhibit the growth of other Gram-positive bacteria(Lai et al. 2010). The interaction 16 
between S.epidermidis and the innate immune system, together with the lack of an 17 
acquired immune system could lead to the inhibition of the growth of other bacteria, 18 
resulting in the reduction of diversity that we observe. However, more research is 19 
needed and other possible explanations, related or not to the active inhibition of other 20 
bacteria by S. epidermidis, should also be considered.  21 
 From a complex system point of view, skin can be considered, depending on the 22 
15 
 
source, as a multidimensional system with three main types of variables, host, 1 
microbial, and environmental, which interact and lead it to a transient system 2 
equilibrium. This equilibrium state will be maintained while all variables are constant, but 3 
changes in any of them would change drastically the whole system(Moya et al. 2008; 4 
Bäckhed et al. 2005; Ley et al. 2008). Previous studies have shown that a microbial shift 5 
may lead to altered inflammatory states and impaired healing during diabetic wound 6 
progression(Scharschmidt et al. 2009; Grice et al. 2010). The latter studies exemplify 7 
the rupture and recomposition of a system when equilibrium is altered and progresses 8 
through a pathogenic state. However, we present here an example of a non-pathogenic 9 
system in which an indirect element of the system is altered leading to a shift in 10 
microbiota without any pathogenic associated condition. In this case, differences 11 
between cohorts are anthropically engineered, eliminating the acquired immune system 12 
of one of the populations. The marked reduction of CD3+, CD4+, CD8+ lymphocyte 13 
populations, will be translated to a reduction in the adaptive inflammatory response to 14 
any pathologic or not pathologic infection. It seems, then, that the only way to maintain 15 
Staphylococcus spp. below a certain threshold level is through the acquired immune 16 
system(M. Li et al. 2007). But, while the acquired host defense against S.epidermidis is 17 
less well understood, we can speculate, from these results, that the acquired immune 18 
system may be the main force maintaining the equilibrium of normal microbiota. Further 19 
research is certainly needed to investigate this possibility. Moreover, given that most 20 
samples, independently of their origin, presented one main S.epidermidis phylotype, this 21 
result suggests the existence of a dominant strain that was particularly apt at colonizing 22 
16 
 
skin, while other phylotypes appeared later and competed with varying degrees of 1 
success. 2 
 The skin microbiome has been considered as a putative triggering factor for 3 
complex diseases such as psoriasis or atopic dermatitis(Gao et al. 2008; Dekio et al. 4 
2007). Common inflammatory diseases present an exacerbation of the activity of the 5 
innate immune system activity against the target tissue, in this case the skin, with some 6 
commonalities with the innate response to infection(Sun et al. 2006; Lande et al. 2007). 7 
However, no important differences have been found in bacterial composition of the skin 8 
that could be considered as a triggering factor for such diseases. Previous studies on 9 
the involvement of bacteria in the development of complex diseases have been 10 
performed once the symptoms had already appeared(Dekio et al. 2007; Gao et al. 11 
2008); even in the case of a real involvement, the triggering factor can be far back in 12 
time and location and consequently highly masked by the adaptation of the whole 13 
system to the new situation. In consequence, further analyses are needed to establish 14 
whether the microbiota triggers the change of the state or the state induces the change 15 
in the microbiota. This would be crucial to the understanding of the complex host-16 
microbiota-environment system. Our observation was not associated to any pathological 17 
state, suggesting that, in this particular case, staphylococcal dominance is a 18 
consequence, and not a cause, of the altered condition, and is not apparently followed 19 
by a pathogenic state. The analysis of serial samples may shed light on Staphylococcus 20 
- host relationships and will result on a better understanding of the complex skin system. 21 
22 
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 1 
CONCLUSIONS 2 
 In this work, under a highly controlled environment and careful sampling scheme, 3 
we have been able to observe patterns of bacterial diversity associated to skin of mice 4 
which can be replicated among individuals. Given that skin is in constant interaction with 5 
the environment and the previous information about the high variability in skin 6 
microbiota, the stringency in the sample preparation is crucial to further skin 7 
metagenomic studies involving health and pathogenic states.  8 
 Our observations suggest that the anatomically normal skin of immunodeficient 9 
mice is gradually colonized by Staphylococcus. That is, we have been able to describe 10 
a dramatic change in the composition of the bacterial community of the skin that is 11 
triggered by a remote event and that does not lead to an apparent pathogenic state. 12 
This observation may contribute to understanding the host-commensal relationships, 13 
and how the disruption of this homoeostasis can be related to skin disease.  14 
15 
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EXPERIMENTAL PROCEDURES 1 
 2 
Mouse skin sampling 3 
Ten healthy wild type and ten immunodeficient (ID) 8 week-old male mice were 4 
euthanized according to a local IRB-board (PRBB, IACU committee) approved protocol, 5 
and a region of 3x3cm was excised from the dorsum-lumbar region, using a sterile 6 
blade, and frozen in liquid nitrogen to preserve the integrity of the skin. Healthy (H) mice 7 
belonged to the C57BL/6J strain, and were provided by Charles River (Wilmington, MA) 8 
and ID mice, provided by the same company, belonged to the C.B-17/Icr-9 
PrkdcSCID/IcrIcoCrl strain(Bosma et al. 1983). These mice are homozygous for the 10 
severe combined immune deficiency spontaneous mutation Prkdcscid, and are 11 
characterized by the absence of functional T cells and B cells, lymphopenia, 12 
hypogammaglobulinemia, and a normal hematopoietic microenvironment. These strains 13 
were initially chosen because they have been reared at our animal facility for a large 14 
number of generations and are perfectly adapted to this environment, reducing possible 15 
variation introduction from the suppliers(Rodrigue & Lavoie 1996). We consider that the 16 
genetic variation among H and SCID mice is low enough to accept C57BL/6J mice as 17 
controls for this study. The genetic background of SCID mice is an admixture of Balb/c 18 
and C57BL/6J strains, and the genomic differences between these two strains are 19 
around 30,000 SNPs, with less of 10% of these SNPs located in coding or regulatory 20 
regions(Keane et al. 2011; Mouse Genome Sequencing Consortium et al. 2002). 21 
 Moreover, environmental factors such as skin region, supplier, hygienic and 22 
19 
 
feeding ranges, and social behaviour have been considered as the most important 1 
factors introducing variability in skin microbial diversity. Then, to reduce as much as 2 
possible the effect of these factors in the study, ID and H parental mice were acquired 3 
from the same supplier. The mice used in this study were born and housed in the same 4 
room, with identical feeding and hygienic rates, allowing them to freely exchange their 5 
microbiota. All the processes involving mice were accredited by AAALAC international. 6 
 Skin samples were subsequently split, under freezing conditions to preserve all 7 
genetic material, using a 4mm punch blade and stored at -80ºC for subsequent 8 
experiments.  9 
Immunohistochemistry 10 
One cylindrical portion from each individual, 4mm wide 5mm deep was stored in 11 
neutral-buffered formalin for 24h before embedding in paraffin, after partially removing 12 
hair. Hematoxilin-Eosin (H-E) staining was performed to assess possible structural 13 
disruption on immunocompromised skin. To assess immune cell infiltration or underlying 14 
infection process, CD3, CD4 and CD8 staining with a primary rabbit anti-mouse 15 
antibody (1:20 dilution, Dako, Glostrup, Denmark) was performed on paraffin-embedded 16 
tissue sections. Biotin-labeled goat anti-rabbit secondary antibody was used (1:500 17 
dilution. Dako), and stained with AEC Substrate kit (Vector Labs, Burlingame, CA). 18 
Staining tissue sections were visualized with a Leica AF6000 E Image acquisition 19 
station (Leica Microsystems, Netzlar, Germany). 20 
 21 
16S rDNA amplification and sequencing 22 
20 
 
DNA was extracted from a skin portion of comparable weight for each individual, with 1 
the DNeasy tissue kit (Qiagen, Valencia, CA) following the modified protocol for Gram 2 
positive bacteria and adding a homogenization step with a mechanical homogenizer IKA 3 
Ultraturrax (Thermo Scientific, Waltham, MA). Double strain DNA was quantified with 4 
PicogreenTM (Thermo Scientific). For each mouse, two replicate 50µL-25cycle PCRs 5 
were prepared using fusion primers (AdaptorA-10-nt barcode-8F, AdaptorB-355R) for 6 
the Titanium 454 platform (Roche Applied Science. Penzberg. Germany) which amplify 7 
the V1-V2 region of the 16S rDNA. Products of both PCR reactions were pooled 8 
together, purified by filtration (Macherey-Nagel, Bethlehem, PA) and quantified with 9 
PicogreenTM(Ley et al. 2005; Stiller et al. 2009). Tagged-PCR products were then pooled 10 
together and sequenced with the FLX-Titanium platform following the manufacturer’s 11 
guidelines for fusion primers with an expected 10,000 reads per sample to saturate the 12 
expected diversity according to previous diversity studies in mouse and human 13 
skin(Grice et al. 2010; Gotelli & Colwell 2001; Costello et al. 2009). Only reads between 14 
150 and 350 bp, and average quality score ≥ 30, and with assignable or correctable 15 
tags were included in the analysis. Filtered reads were separated by barcode using a 16 
customized Perl script (M.Garcia-Garcerà, unpublished), clustered using a similarity 17 
threshold of 99% with CD-HIT(W. Li & Godzik 2006), and a representative sequence 18 
(phylotype) of each cluster was aligned against the RDP database using the Infernal 19 
(Cole et al. 2009; Nawrocki et al. 2009) alignment software.  20 
 21 
16S rRNA diversity and distribution 22 
21 
 
 Sequences were assigned to a specific taxon following the NCBI taxonomy. In 1 
case of taxonomic ambiguity in the Infernal result, the read was assigned to the lowest 2 
common taxonomic level using a modification of the lowest common ancestor (LCA) 3 
algorithm that allows to set the deepest taxonomic level accepted(Alstrup et al. 2004). In 4 
case that the result was over that level, the read was assigned as “no rank” and 5 
removed from subsequent analyses. Unique sequences were also removed from the 6 
analysis to avoid missassignment. Only phylotypes with at least 3 reads assigned 7 
(which are called singletons) were considered for this study.  8 
 Relative diversity and richness were estimated with both Chao1 and Shannon 9 
and Simpson indexes using the vegan R package(Oksanen et al. 2011). Rarefaction 10 
curves were also calculated using the same library to assess the diversity saturation by 11 
the number of reads.  12 
 Similarity patterns among samples were visualized by correspondence analysis 13 
and the difference in bacterial composition present in each mouse group was tested for 14 
with a 2-tailed Student's t-test. 15 
 16 
Quantitative PCR validation of diversity estimates 17 
 To measure the relative abundance of bacteria among samples, 20 ng of DNA 18 
were amplified using 1 mM of each 16s rDNA gene primers 63F and 355R(Castillo et al. 19 
2006), 5 µL of FastStart SYBR green master mix (Roche Applied Science) and 20 
nuclease-free water to a final volume of 10µL. All reactions were performed three times. 21 
Quantitative PCR (qPCR) reactions were performed in a LigthCycler 480 II instrument 22 
22 
 
under manufacturer’s instructions for SYBR green analysis, using the basic relative 1 
quantification protocol. The relative abundance of Staphylococcus species in all 2 
samples was assessed by performing qPCR previously, using the TstaG422-F and 3 
TstaG765-R primers, which specifically amplify Staphylococcus sequences(Martineau 4 
et al. 2001; Morot-Bizot et al. 2004). These primers are specific for a 300bp region of 5 
the tuf gene for Staphylococcus species, and do not amplify this region in other families, 6 
allowing us to specifically quantify the relative amount of staphylococci on our samples. 7 
The three amplification curves obtained for each sample were averaged. Cq values 8 
were calculated for each curve and relative values were calculated and normalized for 9 
each sample taking as standard the output of the 16S rDNA gene amplification(Higuchi 10 
et al. 1993; Bustin et al. 2009). For each sample, differences between 16S rDNA and 11 
TstaG region amplification were calculated inferring the Cq50 value, understood as the 12 
PCR cycle that achieved half the maximum fluorescence intensity. The normal 13 
distribution of Cq50 was tested using Lilliefors test(Lilliefors 1967), and differences 14 
between groups were statistically tested using a two-tailed Student’s t-test unpaired for 15 
the first comparison. Differences within groups were also tested using ANOVA. 16 
 17 
Phylogenetic analysis of Staphylococcus reads 18 
 16S rDNA sequence reads assigned to the family Staphylococcaceae in our 19 
samples were further analyzed phylogenetically by comparing them to a fixed reference 20 
tree, which was constructed using all complete Staphylococcaceae 16S rDNA 21 
sequences in the RDP database(Wang et al. 2007; Cole et al. 2009; Cole et al. 2007). 22 
23 
 
Redundant sequences were removed from the analysis using the greedy incremental 1 
clustering algorithm implemented on CD-HIT(W. Li & Godzik 2006). The remaining 2 
sequences were aligned using SSU-align(Kolbe 2009), manually adjusted and trimmed 3 
with trimAL v. 1.3(Capella-Gutierrez et al. 2009). A phylogenetic tree was constructed 4 
from the resulting alignment with RAxML v. 7.2.8(Stamatakis et al. 2005), using the 5 
GTR substitution matrix without invariant positions and estimation of the gamma 6 
distribution as the best-suited evolutionary model for our dataset as determined by 7 
jModelTest v. 0.1.1(Rodríguez et al. 1990; Posada 2008) using a Maximum Likelihood 8 
seed tree. Redundant information was removed from the analysis with the option prune 9 
of ETE(Huerta-Cepas et al. 2010). Phylotypes assigned to the Staphylococcaceae 10 
family in our samples were realigned to the reference Staphylococcaceae alignment 11 
with SSU-align to assess differences on the distribution of Staphylococcus sp. between 12 
both samples. The same diversity measures were applied to the phylotype distribution 13 
along the reference tree using the R vegan package(Oksanen et al. 2011; Ikaha & 14 
Gentleman 1996). 15 
16 
24 
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 1 
FIGURE LEGENDS 2 
 3 
Figure 1. Comparison of the relative abundances (x10,000) of bacteria in skin 4 
samples.  5 
16S sequences were assigned to the genus level. Only genera with more than three 6 
sequences assigned were used for the analysis; then the whole information was 7 
clustered to family level. Uncommon/rare families were clustered together into class 8 
level. For more detailed information, see the supplementary material.  9 
 10 
Figure 2. Correspondence analysis of the bacterial diversity in skin of 11 
immunodepressed and healthy mice. 12 
Samples clustered together according to  health state using Correspondence Analysis 13 
(PCoA) of the unweighted UniFrac distance matrix. Samples are shown by name, and 14 
the different taxa are colored by class. Components 1 and 2 together explain > 95% of 15 
the variance. DCA1 (72% of explained variability) is associated to the relative 16 
abundance of Staphylococcus assigned reads, resulting in a marked divergence 17 
between the ID samples and the ones that behave as healthy (including ID4 and ID10, 18 
which have similar diversity than the healthy ones).  19 
 20 
Figure 3. Phylogenetic analysis of the Staphylococcacae assigned reads. 21 
16S sequences belonging to the Staphylococcaceae family were obtained from the 22 
RDP database to construct a reference. 23 
24 
30 
 
 1 
 2 
 3 
 4 
sample Shannon Chao1 SE,Chao1 ACE SE,ACE 
1ID 0.020 11 11.7 14.24 1.513 
2ID 0.009 4 1.3 5.11 1.136 
3ID 1.078 13 0.7 14.17 1.769 
4ID 1.302 21 NaN 23.09 1.975 
5ID 0.506 29 10.3 39.96 4.164 
6ID 1.521 22 NaN 22.00 1.809 
7ID 0.032 7.5 3.7 9.22 1.355 
8ID 0.229 3 NaN NaN NaN 
9ID 1.697 21 NaN 21.00 2.268 
10ID 2.167 26 NaN NaN NaN 
1H 1.832 21 NaN NaN NaN 
2H 1.206 8 NaN 8.00 0.935 
3H 1.434 21.86 1.85 24.28 2.409 
4H 2.167 23 NaN NaN NaN 
5H 2.187 23 NaN NaN NaN 
6H 1.213 10 NaN NaN NaN 
7H 1.392 17 NaN 18.56 2.195 
8H 1.402 22 0 22.00 2.185 
9H 2.248 23 NaN 23.00 2.106 
10H 1.827 26 0 26.00 2.148 
 5 
 6 
 7 
 8 
 9 
 10 
Table 1. Diversity of microbial families for the 20 samples analyzed. Diversity 11 
indeces were calculated for each sample given a family-based abundance table. 12 
SE, Standard Error; ACE, Abundance-base Coverage Estimator. Undefined (NaN) 13 
values appear when all rare taxa are only assigned as singletons.  14 
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